Document is current
Any future updates will be listed below
-
Authors
Avadzadeh, Sahar
Sharma, Ashish https://orcid.org/0000-0002-8550-9791
Parvaresh, Mohammad Mehdi
Ghasemi Falavarjani, Khalil https://orcid.org/0000-0001-5221-1844
,
Kuppermann, Baruch D.
Loewenstein, Anat
Bandello, Francesco
Regillo, Carl D.
Nicholson, Luke
Vazquez-Alfageme, Clara
Kumar, Nilesh
Parachuri, Nikulaa
Sheth, Jay
Ayachit, Seemantini
Mishra, Chitaranjan
Chakraborty, Debdulal
Banker, Alay
Rezaei, Kourous A.
Khanani, Arshad M.
Kaiser, Peter K.
Holz, Frank G.
Sivaprasad, Sobha
Wakabayashi, Taku
Querques, Giuseppe
Özdek, Şengül
Laurent, Kodjikian
Bilgic, Alper
Lanzetta, Paolo
Baumal, Caroline
Holekemp, Nancy
Sakamoto, Taiji
Tufail, Adnan
Yannuzzi, Nicolas
Corradetti, Giulia
Hilely, Assaf
Boyer, David
Rachitskaya, Aleksandra
Peto, Tunde
Wintergerst, Maximilian WM
Sarao, Valentina
Parolini, Barbara
Mruthyunjaya, Prithvi
Nguyen, Quan Dong
DO, Diana V.
Keane, Pearse A.
Hassan, Tarek
Sridhar, Jayanth
Eichenbaum, David
Grewal, Dilraj S.
March, Francesc
Spitzer, Martin
Zinkernagel, Martin S.
Ueda-Consolvo, Tomoko
Ishida, Masaaki
Nakamura, Tomoko
Yanagisawa, Shuichiro
Tsuboi, Kotaro
Hayashi, Atsushi
Woo, Se Joon
Sagong, Min
Lee, Christopher Seungkyu
- License Information
-
More Information
Article History
Received: 3 November 2024
Revised: 7 March 2025
Accepted: 22 April 2025
First Online: 3 May 2025
Competing interests
: KGF: Consultant for CinnaGen. Ashish Sharma: Consultant for Bayer, Lupin, Novartis, Allergan, Roche and Intas. SA and MMP: None.
